Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Michael Leader, M.D.,Ph.D.

Concepts (79)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Andrew Leader's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andrew Leader has written about over time.
Cerium, 1 publications between 2017 and 2017, average publication date August 2017. Single-Cell Analysis, 4 publications between 2017 and 2021, average publication date February 2019. Dendritic Cells, 3 publications between 2017 and 2020, average publication date May 2019. Macrophage Colony-Stimulating Factor, 1 publications between 2019 and 2019, average publication date July 2019. Purkinje Cells, 1 publications between 2019 and 2019, average publication date July 2019. Tumor Microenvironment, 4 publications between 2017 and 2022, average publication date October 2019. Macrophages, 4 publications between 2017 and 2023, average publication date April 2020. Killer Cells, Natural, 2 publications between 2017 and 2023, average publication date April 2020. Lung Neoplasms, 7 publications between 2017 and 2023, average publication date August 2020. Science, 1 publications between 2020 and 2020, average publication date September 2020. Immunotherapy, 4 publications between 2019 and 2022, average publication date February 2021. Carcinoma, Non-Small-Cell Lung, 3 publications between 2020 and 2021, average publication date March 2021.

To see the data from this visualization as text, click here.
Leader's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (79)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.